Medication-Assisted Treatment, including Sublocade and others
MOUNTAINSIDE IS ONE OF FEW ADDICTION TREATMENT CENTERS OFFERING SUBLOCADE
Mountainside has added Sublocade™ – a monthly injectable buprenorphine product for the treatment of moderate to severe opioid use disorder (OUD) – to the addiction medications available throughout its continuum of care.
Sublocade is available through Mountainside’s Medication-Assisted Treatment (MAT) program. The MAT program already provides Vivitrol® (extended-release naltrexone available as a monthly injection) and Suboxone® (buprenorphine and naloxone available as a sublingual film strip).
Sublocade is the first monthly injectable formulation of extended-release buprenorphine on the market. It has been available for prescrapproved by the U.S. Food and Drug Administration in November of 2017 and . Mountainside was one of a handful of addiction treatment centers in Connecticut licensed to provide the medication to its clients.
Individualized Addiction Treatment
Medication-assisted treatment can be a life-saving, so our expert team will evaluate your health, history of use, and recovery goals to determine whether MAT is right for you. If so, our medical professionals will provide you with a customized plan that meets your needs. Throughout your treatment, they closely monitor your progress, making dosage adjustments as needed. Working closely with you and your clinician, our medical team evaluates your recovery goals and determines whether a maintenance dosage or a medical taper is best for you.
Programs Offering MAT:
- Extended Care
- Outpatient Services
- Recovery Coaching
Learn more about these programs here.